Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 13/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | AURKA | O14965 | 1/20 | 0.50 |
| ▸ | CDK4 | P11802 | 1/20 | 0.50 |
| ▸ | BRD4 | O60885 | 8/20 | 0.48 |
| ▸ | PTK2 | Q05397 | 4/20 | 0.47 |
| ▸ | JAK3 | P52333 | 3/20 | 0.47 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.43 |
| ▸ | STAT6 | P42226 | 2/20 | 0.43 |
| ▸ | AXL | P30530 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1655002 | 0.88 | JAK2 (0.54) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL3403256 | 0.88 | AURKA (0.52) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL1655049 | 0.87 | AURKA (0.64) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL1655187 | 0.87 | AURKA (0.54) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL4293250 | 0.86 | AURKA (0.56) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL3399195 | 0.85 | AURKA (0.55) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL1655013 | 0.85 | JAK2 (0.61) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL3399191 | 0.84 | JAK2 (0.62) | JAK2HDAC6AURKACDK4BRD4 | |
| SCHEMBL27915953 | 0.84 | JAK2 (0.52) | JAK2CDK4BRD4PTK2JAK3 | |
| SCHEMBL4292070 | 0.83 | JAK2 (0.50) | JAK2HDAC6AURKACDK4BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101981036-B | Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors | NOVARTIS AG | 2013-09-04 | — | — | CN | disclosed |